TIB Molbiol Syntheselabor GmbH
Marcus Droege, PhD, MBA is the General Manager at TIB Molbiol Syntheselabor GmbH. With a background in Molecular Genetics and a Master of Business Administration from Purdue University Daniels School of Business, Marcus has held various senior roles in the molecular diagnostics and next generation sequencing industry, including as Commercial Business Leader at Roche Diagnostics International and Head of Sales at Roche Diagnostics Deutschland. With extensive experience in marketing, sales, and leadership positions, Marcus has a proven track record of success in the biotech industry.
This person is not in any teams
TIB Molbiol Syntheselabor GmbH
TIB Molbiol is a medium-sized biotech company based out of Berlin, Germany who has supplied the global market for over 30 years with reagents for research and medical diagnostics. We were recently bought by Roche, one of the largest pharma and biotech companies in the world. Roche has committed to keep the start -up character of the company so that the company can benefit from the advantages of a small biotech and the muscle and power of a large pharma/biotech company such as Roche. Our customers are mainly diagnostic and research labs, servicing patients every day, selecting from any of our more than 2,500 diagnostic kits and LightSNiP assays. We fulfill many special orders for custom design of individual assays, for patient need.